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Abstract Objective: To describe the epidemiology of chromosomal and non-chromosomal cases of atrioventricular
septal defects in Europe. Methods: Data were obtained from EUROCAT, a European network of population-based
registries collecting data on congenital anomalies. Data from 13 registries for the period 2000–2008 were included.
Results: There was a total of 993 cases of atrioventricular septal defects, with a total prevalence of 5.3 per 10,000
births (95% confidence interval 4.1 to 6.5). Of the total cases, 250 were isolated cardiac lesions, 583 were
chromosomal cases, 79 had multiple anomalies, 58 had heterotaxia sequence, and 23 had a monogenic syndrome.
The total prevalence of chromosomal cases was 3.1 per 10,000 (95% confidence interval 1.9 to 4.3), with a large
variation between registers. Of the 993 cases, 639 cases were live births, 45 were stillbirths, and 309 were
terminations of pregnancy owing to foetal anomaly. Among the groups, additional associated cardiac anomalies were
most frequent in heterotaxia cases (38%) and least frequent in chromosomal cases (8%). Coarctation of the aorta was
the most common associated cardiac defect. The 1-week survival rate for live births was 94%. Conclusion: Of all
cases, three-quarters were associated with other anomalies, both chromosomal and non-chromosomal. For infants
with atrioventricular septal defects and no chromosomal anomalies, cardiac defects were often more complex
compared with infants with atrioventricular septal defects and a chromosomal anomaly. Clinical outcomes for
atrioventricular septal defects varied between regions. The proportion of termination of pregnancy for foetal
anomaly was higher for cases with multiple anomalies, chromosomal anomalies, and heterotaxia sequence.
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A
TRIOVENTRICULAR SEPTAL DEFECT, ALSO KNOWN
as endocardial cushion defect, common atrio-
ventricular canal, or complete atrioventricular
canal, is a serious cardiac anomaly with a central
defect involving both the ventricular and atrial
septum and a common atrioventricular valve across
the defect. The defect may be partial or total and
include the dominance of one ventricle – an
unbalanced atrioventricular septal defect – and may
have associated cardiac anomalies resulting in severe
heart failure in early infancy.1 Surgery can be
performed within the first year of life with good
results, but later corrective surgery of one or both
atrioventricular valves may be necessary. Studies show
variations in survival ranging from 65% to 84.1%
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20 years post surgery.2–4 However, none of these
studies included unbalanced atrioventricular septal
defects for which survival is known to be worse.5
Atrioventricular septal defect is often seen in
infants with Down syndrome and other karyotype
anomalies.6 However, studies report a large variation
in the proportion of cases with atrioventricular
septal defect and an associated karyotype anomaly.6,7
A large population-based study from California
showed that 54% of infants with atrioventricular
septal defect had Down syndrome, whereas a study
by Huggon et al found 35.5%.6,7
Few studies have reported the epidemiology of
atrioventricular septal defect, and of those that do
only a very few have been population based.6,7
Atrioventricular septal defect is most commonly
diagnosed prenatally within the second trimester,
although some cases may be diagnosed earlier.8,9
After the prenatal diagnosis of atrioventricular
septal defect, health professionals may inform the
parents of the risk of Down syndrome and other
anomalies, and may offer prenatal karyotype testing.
Accurate data on the epidemiology and survival of
atrioventricular septal defect will be very useful in
the counselling of parents when a prenatal diagnosis
of atrioventricular septal defect is made.
The aim of this study is to describe the epidemio-
logy of atrioventricular septal defect, particularly
the prevalence of chromosomal and non-chromosomal
atrioventricular septal defect.
Materials and methods
Data analysed in this study were obtained from
EUROCAT, a European network of population-based
registries collecting data on congenital anomalies.
EUROCAT obtains information on foetuses and
infants born with major congenital and chromosomal
anomalies. Minor anomalies are disregarded accord-
ing to the EUROCAT list of exclusions (http://www.
eurocat-network.eu/aboutus/datacollection/guidelines
forregistration/malformationcodingguides). Informa-
tion is obtained from hospital records, post-mortem
examinations, and birth and death certificates.
EUROCAT covers more than 1.5 million births per
year from 43 registries in 20 countries (www.eurocat-
network.eu).10,11 For this study, all full member
EUROCAT registries were invited to participate. Data
from 13 registries covering 993 cases of atrioven-
tricular septal defect (International Classification of
Diseases-9 and -10 codes 7456 or Q21.2) from 2000
to 2008 were included. Not all registries covered the
entire study period. Cases were classified into four
different groups using a computer algorithm.12 Each
case was classified according to associated non-cardiac
anomalies and allocated in groups of either isolated
cardiac anomaly, chromosomal anomalies, monogenic
syndrome, or potentially multiple anomaly. The
potentially multiple anomaly cases were manually
reviewed by three of the authors – Ester Garne, Diana
Wellesley, and Nikolas Christensen. Multiple con-
genital anomaly was defined as a minimum of two
major congenital anomalies in two different organ
systems. During the manual review, cases were
allocated to a new subgroup: heterotaxia sequence.
Heterotaxia sequence was defined as two or more of
the following anomalies: asplenia/polysplenia, bilat-
erally bi- or trilobed lungs, situs inversus, midline
liver, right-sided stomach, intestinal malrotation,
dextrocardia, or atrial isomerism.1,13–15 If other
organs were involved, the case was classified as
multiple congenital anomaly.
All cardiac defects were reviewed manually (Helle
Andersen and Nikolas Christensen), and cases not
compatible with atrioventricular septal defect were
excluded. The diagnosis of atrioventricular septal
defect was subdivided into either isolated complete
atrioventricular septal defect, isolated primum
atrial septal defect, atrioventricular septal defect
with associated cardiac defects, or unbalanced
atrioventricular septal defect. Cases with the text
partial or incomplete atrioventricular septal defect
were categorised as primum atrial septal defect.
Unbalanced atrioventricular septal defect includes
cases with a hypoplastic ventricle or hypoplastic
left/right heart syndrome.
Prevalence and epidemiological data – type of
birth, birth weight, gestational age at prenatal
discovery, 1-year survival, and maternal age – will
be given for each group.
Descriptive analyses were performed and Chi-square
test was used for statistical testing. The level of
significance was set at 0.05.
The total number of births covered in the 13
registries was 1,865,403.
Results
During the 9-year study period, a total of 993 cases
of atrioventricular septal defect were diagnosed,
with a total prevalence of 5.3 per 10,000 births
(95% confidence interval 4.1 to 6.5). Live births
accounted for 639 cases (64%). Stillbirths were
present in 45 cases (5%). In 309 cases (31%), there
was a termination of pregnancy owing to foetal
anomaly, accounting for 54% of those prenatally
diagnosed.
Table 1 shows the prevalence of atrioventricular
septal defect in the 13 registries. The total pre-
valence of atrioventricular septal defect varied from
2.1 per 10,000 births in Antwerp, Belgium,
to 7.0 in Switzerland. There was a significant
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Table 1. Birth type and prevalence of the different European regions during 2000–2008.
Registry
Total
births
Total
cases
Live
births
(%)
Stillbirths
(%)
Termination
of pregnancy
for foetal
anomaly (%)
Total
prevalence*
Total
chromosomal
cases (%)
Non-
chromosomal
cases
Chromosomal
prevalence*
Non-
chromosomal
prevalence*
Percentage
prenatally
diagnosed
of total
cases
Percentage
prenatally
diagnosed of
chromosomal
cases
Percentage
prenatally
diagnosed of
non-
chromosomal
cases
Median
gestational
age at
diagnosis for
non-
chromosomal
cases
Switzerland 65,459 46 22 (48) 1 (2) 23 (50) 7,0 27 (59) 19 (41) 4,1 2,9 70 93 37 20
Northern England
(United Kingdom)
280,909 188 131 (70) 9 (5) 48 (26) 6,7 103 (55) 85 (45) 3,7 3,0 59 61 55 20
Paris (France) 251,255 166 62 (37) 10 (6) 94 (57) 6,6 109 (66) 57 (34) 4,3 2,3 87 87 86 22
Cork and Kerry
(Ireland)**
49,898 32 31 (97) 1 (3) 0 (0) 6,4 23 (72) 9 (28) 4,6 1,8 9 9 11 40
Barcelona (Spain)*** 111,774 67 27 (40) 0 (0) 40 (60) 6,0 46 (69) 21 (31) 4,1 1,9 79 80 76 20
Malta 35,689 21 21 (100) 0 (0) 0 (0) 5,9 15 (71) 6 (29) 4,2 1,7 5 7 0 -
Wales (United
Kingdom)
293,391 171 97 (57) 16 (9) 58 (34) 5,8 98 (57) 73 (43) 3,3 2,5 68 68 67 20
Odense (Denmark) 48,301 26 24 (92) 0 (0) 2 (8) 5,4 8 (31) 18 (69) 1,7 3,7 31 38 28 24
Styria (Austria) 93,484 43 34 (79) 2 (5) 7 (16) 4,6 22 (51) 21 (49) 2,4 2,2 49 55 43 21
Wanda-Wessex
(United Kingdom)
233,004 107 77 (72) 3 (3) 27 (25) 4,6 57 (53) 50 (47) 2,4 2,1 50 44 58 20
Northern Netherlands 172,885 70 63 (90) 3 (4) 4 (6) 4,0 43 (61) 27 (39) 2,5 1,6 23 28 15 20
South-East Ireland 60,727 20 20 (100) 0 (0) 0 (0) 3,3 16 (80) 4 (20) 2,6 0,7 0 0 0 –
Antwerp (Belgium) 168,627 36 30 (83) 0 (0) 6 (17) 2,1 16 (44) 20 (56) 0,9 1,2 31 25 35 30
Total 1,865,403 993 639 (64) 45 (5) 309 (31) 5,3 583 (59) 410 (41) 3,1 2,2 57 59 54 20
*Listed per 10,000 births
**Included the years 2000–2005
***Included the years 2000–2007
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difference between registries in the proportions of
chromosomal and non-chromosomal cases (p-value
, 0.001). The proportion of chromosomal cases
ranged from 31% in Denmark to 80% in South-East
Ireland. In all regions except Antwerp in Belgium
and Odense in Denmark, there were more chromo-
somal atrioventricular septal defect cases than
non-chromosomal atrioventricular septal defect cases.
Significant differences in the distribution between
live births, stillbirths, and termination of pregnancy
owing to foetal anomaly were found among registries
(p-value, 0.001). The highest proportions of live
births were found in Malta, South-East Ireland, Cork
and Kerry, Northern Netherlands, and Denmark
(Z90%). Termination of pregnancy owing to foetal
anomaly ranged from 0% in South-East Ireland,
Cork and Kerry, Ireland, and Malta to 57% and 60%
in Paris, France, and Barcelona, Spain, respectively.
The rate of termination of pregnancy owing to foetal
anomaly varied between regions from 0% to 50%
for chromosomal cases versus 0% to 41% for non-
chromosomal cases.
More than half of all cases were diagnosed with a
chromosomal anomaly (583 cases or 59% of total), of
which 488 cases had trisomy 21. Other karyotype
anomalies included trisomy 18, trisomy 13, Turner
syndrome, Klinefelter syndrome, various deletions,
and unbalanced translocations. Isolated cardiac defects
were seen in 250 cases (25%). Multiple anomalies
and heterotaxia sequence were present in 79 (8%)
and 58 cases (6%), respectively. There were 23 cases
(2% of total) with a monogenic syndrome. The
prevalence for these groups ranged from 0.1 to 3.1
per 10,000 live births, that is, monogenic syndrome
and chromosomal cases, respectively. The distribution
of all cases in individual groups is summarised
in Figure 1. Figure 1 may be a helpful tool when
counselling a pregnant woman with a foetus that
is prenatally diagnosed with an atrioventricular
septal defect.
For cases with chromosomal anomalies, 58% of
cases were live births, for cases with multiple
anomalies 53% were live births, and for cases with
isolated atrioventricular septal defect and no other
cardiac defects 90% were live births.
Of all cases, 57% were diagnosed prenatally.
A large variation was seen between groups. Of cases
of isolated atrioventricular septal defect, 41% were
prenatally diagnosed compared with 83% of cases
with Heterotaxia and 76% of cases with multiple
anomalies. For postnatally diagnosed cases, the
majority were diagnosed within the first month
after birth.
The distributions of the different types of
atrioventricular septal defects are given in Table 2.
For cases with isolated primum atrial septal defect,
most were either an isolated cardiac lesion (47%),
with no other major non-cardiac defects, or had a
chromosomal anomaly (43%). No cases with isolated
primum atrial septal defect had heterotaxia.
Isolated complete atrioventricular septal defect was
the most frequent cardiac setting seen in 72% of total
cases. Among these, 69% of the cases had a chromo-
somal anomaly and 20% of the isolated complete
atrioventricular septal defect had no other cardiac or
non-cardiac anomalies – isolated cardiac lesion.
Of cases with associated cardiac defects, 34%
were isolated cardiac defects and 35% had chromo-
somal anomalies. Heterotaxia was present in 16%
and 13% had multiple anomalies.
Figure 1.
Flowchart showing the distribution of cases with atrioventricular septal defect according to associated cardiac defects. For use in counselling
pregnant women with a prenatally diagnosed foetus with atrioventricular septal defect.
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The median gestational age at prenatal diagnosis
was 21 weeks for isolated primum atrial septal
defect and isolated complete atrioventricular septal
defect and 20 weeks for cases with associated cardiac
defects and unbalanced atrioventricular septal defect.
Table 3 shows the distribution of associated
cardiac defects. Coarctation of the aorta was the
most frequent and was present in 48 cases, that is,
21% of the total associated cardiac defects.
Table 4 shows the 26 syndromes and associations
present with atrioventricular septal defect cases.
The most common were the CHARGE syndrome,
Noonan syndrome, and VATER association.
Table 5 shows the anomalies seen among the
79 cases with multiple malformations. The most
common were limb, urinary, and nervous system
anomalies accounting for 33 (21%), 26 (16%), and
24 (15%)of a total of 159 anomalies, respectively.
Of all 993 cases, 599 (60%) survived beyond the
first week of life. For live births only, the percentage
of survival at 1 week of age was 94% and survival
past 1 week varied between groups from 82%
(Heterotaxia) to 96% (Isolated cardiac) for live
births. For six cases, the outcome at 1 week of age
was unknown.
Discussion
Our European study showed an overall prevalence of
atrioventricular septal defect of 5.3 per 10,000
births (95% confidence interval 4.1 to 6.5), which is
higher than in previously published literature. The
reported prevalence ranges from 2 per 10,000 to
4.4 per 10,000 live births.6,8,16,17 However, these
studies included live-born cases only and only one
study included the entire spectrum of atrioventricular
septal defect.17 The variation in prevalence is also
demonstrated by the regional differences observed
in our study. There was no clear North-South or East-
West European distribution of prevalence present in
our study.
Table 2. Distribution of cardiac defects among groups.
Isolated
cardiac (%)
Chromosomal
(%)
Monogenic
syndrome (%)
Heterotaxia
(%)
Multiple
anomaly (%)
All groups
(%)
Isolated primum atrial septal defect 35 (47) 32 (43) 4 (5) 0 (0) 3 (4) 74 (100)
Isolated complete atrioventricular septal
defect
141 (20) 495 (69) 13 (2) 21 (3) 49 (7) 719 (100)
Associated cardiac defects 47 (34) 49 (35) 4 (3) 22 (16) 18 (13) 140 (100)
Unbalanced atrioventricular septal defect 27 (45) 7 (12) 2 (3) 15 (25) 9 (15) 60 (100)
Total 250 (25) 583 (59) 23 (2) 58 (6) 79 (8) 993 (100)
Table 3. Associated cardiac defects seen among 140 cases.
Defect Number % of total
Coarctation of the aorta 48 21
Pulmonary atresia 28 12
Double-outlet right ventricle 26 11
Hypoplastic left or right ventricle 26 11
Transposition of the great arteries 24 10
Tetralogy of Fallot 20 9
Anomalous venous return 17 7
Other 40 17
Total 229 100
Table 4. Syndromes and associations among cases with
atrioventricular septal defects.
Syndrome Number % of all syndromes
CHARGE 4 15
Noonan syndrome 3 12
VATER 3 12
Holt–Oram syndrome 2 8
Smith–Lemli-Opitz 2 8
Foetal alcohol syndrome 2 8
Cornelia de Lange 1 4
Goldenhar syndrome 1 4
Wardenburg 1 4
Other/unspecified 7 27
Table 5. Additional congenital anomalies in cases with
atrioventricular septal defects.
Affected organs Number
Limb 33
Urinary 26
Nervous system 24
Digestive system 18
Orofacial clefts 13
Musculoskeletal 12
Respiratory 10
Genital 8
Others 7
Abdominal wall defects 5
Eye 2
Ear, face, and neck 1
Total 159
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In our European population, 64% of all atrioven-
tricular septal defect cases were live births and 31%
resulted in a termination of pregnancy for foetal
anomaly. In other studies, the proportions of birth
types are reported with some variation. Studies on
prenatally diagnosed atrioventricular septal defects
mostly show a lower proportion of live births
than found in this study.7–9,18–20 Delisle et al21 and
Allan22 included postnatally diagnosed cases, and
the proportion of live births in these studies
correlates well with our findings.
The highest proportion of termination of preg-
nancy for foetal anomaly cases in our study was seen
in cases with multiple anomalies, chromosomal
anomalies, and heterotaxia. Yıldırım et al did not
find any significant increase in termination of
pregnancy for foetal anomaly among cases with
more complex cardiac lesions compared with those
with isolated cardiac defects.19 Culture, prenatal
screening policies, and local legislation in relation
to termination of pregnancy for foetal anomaly may
influence this proportion.23
Regional variation in chromosomal prevalence
was seen in our study (Table 1). In regions with
first-trimester screening for Down syndrome, the
gestational age at termination of pregnancy for
foetal anomaly might be too low for the diagnosis of
atrioventricular septal defect either by ultrasound or
by post-mortem examination. In the Danish registry,
only 31% of all atrioventricular septal defect cases
were reported to have a chromosomal anomaly. In
this region, chorion villus sampling was the preferred
invasive test offered for Down syndrome screening at
a gestational age of 12–13 weeks to women from
35 years in the period 2000–2004, and from 2005
the first trimester combined screening was offered to
all women.24 With the increasing use of first-
trimester screening for Down syndrome in Europe,
the overall prevalence and the chromosomal pre-
valence of diagnosed atrioventricular septal defect is
expected to decrease.
In this study, chromosomal anomalies accounted
for the majority of cases and Down syndrome
was, as expected, the dominant chromosomal
anomaly.7–9,18–21,25,26 Cases with isolated cardiac
defects comprised a quarter of the total cases. This
corresponds well with other studies.21,25 However,
studies including only prenatally diagnosed cases
are likely to be over-represented with more complex
cases.7,18,22
The proportion of heterotaxia sequence has been
reported with large variation ranging from 6% to
45%.5,8,9,14,17,20–22,25 In our study, we found hetero-
taxia in 6% of the cases. The proportion and type of
monogenic syndromes in our study are similar to
previously published studies.25,27
Isolated primum atrial septal defect was the
cardiac lesion in 74 cases (7% of total cases). This
figure may be underestimated in our study, as
isolated primum atrial septal defect is more difficult
to diagnose and therefore might not be diagnosed
within the first year of life.14,26,28 Isolated primum
atrial septal defect was mainly seen in patients with
isolated cardiac lesions (47%) or chromosomal
anomalies (43%), as has also been reported by
Paladini et al26 No cases with isolated primum
atrial septal defect had heterotaxia sequence in our
study. Geva et al14 have noted that heterotaxia is
more common in cases with complete atrioventri-
cular septal defect than primum atrial septal defect.
Our study shows a strong association between
isolated complete atrioventricular septal defect and
chromosomal anomalies. This association is well
known, especially the association with Down
syndrome.7–9,16,18,20,21,25,29
Atrioventricular septal defect is often reported with
associated cardiac defects. In our study, 140 cases with
atrioventricular septal defect had 229 associated
cardiac defects. The frequency of individual cardiac
lesions has been reported with some inconsistency in
the published literature.7,9,14,18–20,26,29,30 We found
that coarctation of the aorta was the most prevalent,
accounting for 21% of all associated cardiac defects.
For live-born infants with atrioventricular septal
defect, overall survival past the first week of life was
94% with some variation between groups. Cases
with heterotaxia had the lowest survival rate,
whereas cases with isolated cardiac lesions had the
highest survival rate, as has been shown in other
studies.7,17,19,20,22 Atrioventricular septal defect
associated with Down syndrome has been reported
to have a better survival than non-Down syndrome
cases probably because of a lower proportion of
severe associated cardiac defects.3,9 However, we
found no significant difference in 1-week survival
between chromosomal cases and non-chromosomal
cases, as seen by Huggon et al7
Studies on prenatally diagnosed atrioventricular
septal defects report poorer outcomes compared
with studies on postnatally diagnosed cases.7,8
Surgical studies also report a high survival rate.3,7,16
Surgical studies often exclude cases not suitable for
surgery or those who die before surgery can be
performed.7 Therefore, caution should be used if
using these studies in the counselling of parents
with a foetus with a prenatal diagnosis of an
atrioventricular septal defect.8
This study has a number of strengths. To our
knowledge, it is the largest of its type. All cases
have been thoroughly reviewed for classification of
cardiac defects and syndromes, although our review
was based solely on the International Classification
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of Diseases-9 and -10 codes given by the local
registries. Data for the study are population based
and have been routinely collected for many years
using the same methodology and without bias for
this specific cardiac defect.
A weakness of this study is that no cases were
included if the diagnosis was made after 1 year of
life. This underestimates the prevalence of primum
atrial septal defect, as this defect may go unnoticed
for years. This study was of a European population
and may not be representative for other parts of the
world or all ethnicities.31,32 Furthermore, for cases
with non-isolated atrioventricular septal defect or
chromosomal anomalies, it is uncertain whether the
atrioventricular septal defect or another anomaly
was diagnosed first.
Conclusion
The total prevalence of atrioventricular septal defect
in Europe was 5.3 per 10,000 births (95% confidence
interval 4.1 to 6.5). In our study, three-quarters of all
atrioventricular septal defect cases were associated
with chromosomal disorders or other congenital
anomalies. Of the 25% with only cardiac defects,
30% had associated cardiac defects or unbalanced
atrioventricular septal defect. The proportion of
termination of pregnancy for foetal anomaly was
high for cases with multiple anomalies, chromosomal
anomalies, and heterotaxia sequence. For infants with
atrioventricular septal defect and no chromosomal
anomaly, cardiac defects were more often complex
compared with infants with atrioventricular septal
defect and a chromosomal anomaly.
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